TissueGene aims for $179m in Kosdaq float
US-based TissueGene has announced an indicative range for its Kosdaq listing of W202.5bn ($179.1m), with bookbuilding expected to start next month.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts